XRAYDENTSPLY SIRONA Inc.

$10.94

The financials

DENTSPLY SIRONA Inc. by the numbers

DENTSPLY SIRONA Inc. (XRAY) reported revenue of $880M in Q1 2026 (quarter ended March 31, 2026), up 0.1% from the same quarter a year earlier. That came with a gross margin of 49% and net loss of $10M. For the full year FY2025, revenue was $3.68B (−3.0% year on year) and net income −$598M. Its largest product in 2026-Q2 was Implants And Prosthetics at $157M, 36% of the disclosed total, just ahead of Equipment And Instruments at 31%.

DENTSPLY SIRONA Inc. income statement, Q1 2026 against the same quarter a year earlier
Income statementQ1 2026Q1 2025Change
Revenue$880M$879M+0.1%
Gross profit$427M$466M−8.4%
Operating income−$35M$63Mto a loss
Net income−$10M$20Mto a loss
Diluted EPS−$0.05$0.10to a loss
Revenue by product, 2026-Q2, as reported to the SEC
ProductRevenueShare
Implants And Prosthetics$157M36%
Equipment And Instruments$137M31%
CADCAM$102M23%
Orthodontics$40M9.2%

Business Segments

Revenue split by product segment, from SEC XBRL filings.

Latest period: Q2 2026Total $436.0M (-2.0%)
Equipment And Instruments grew +0.74% year on yearOrthodontics -37% year on year
  • Implants And Prosthetics$157.0MQoQ +1.9%year on year -3.7%
  • Equipment And Instruments$137.0MQoQ +1.5%year on year +0.74%
  • CADCAM$102.0MQoQ -8.1%year on year -4.7%
  • Orthodontics$40.0MQoQ -11%year on year -37%
Segment sum = 49% of reported consolidated revenue (partial disaggregation) · Latest source: 10-Q filed 2026-08-06, SEC EDGAR